Novo Nordisk Bets $200M on Triple-Targeting Drug for Obesity and Other Metabolic Diseases

Posted Monday, March 24, 2025 1:22 pm

Frank Vinluan (via MedCity News)

Novo Nordisk is licensing rights to a United Biotechnology drug that sparks metabolic effects by binding to and activating receptors for GLP-1, GIP, and glucagon. Separately, the pharma giant said its recently announced discounted price for obesity medication Wegovy is now expanding to traditional pharmacies. The post Novo Nordisk Bets $200M on Triple-Targeting Drug for Obesity and Other Metabolic Diseases appeared first on MedCity News.

Continue reading at MedCity News »

Keywords

BioPharma, Daily, Pharma, Pharmacy, biopharma nl, Clinical Trials, deals, metabolic disorder, Novo Nordisk, Obesity, type 2 diabetes, weight loss drug

Top stories

My Doctor Saved My life, Diabetes Tech Gave Me Control

(NewsUSA) - Troy Ita’s life was turned upside down by diabetes. Thankfully, he doesn’t have to compromise lifestyle or family time with the help of groundbreaking technology. Family is at the …

Sunscreen: You’re Not Fully Dressed Without It

(NewsUSA) - If you put on socks this morning but skipped the sunscreen, you’re doing it wrong — at least according to a new nationwide campaign launched on World Health Day earlier this …

Step Into Spring – Don't Let Varicose Veins Stop You

(NewsUSA) - As the cold of winter fades, spring brings a fresh sense of renewal—and for many, it’s the first time in months they’ll be showing off their legs again. But for some, the thought of …

Spring Into Action – Don't Let Varicose Veins Hold You Back

(NewsUSA) - As the cold of winter fades, spring brings a fresh sense of renewal—and for many, it’s the first time in months they’ll be showing off their legs again. But for some, the thought of …

Expanding Coverage for FDA-Approved GLP-1s Is Critical for Patient Safety

(NewsUSA) - The newest generation of GLP-1 drugs has delivered life-changing benefits to patients managing diabetes, obesity, heart disease, and other chronic health conditions. And yet even though …

From the web

WHO countries finalize historic agreement to help prevent next pandemic

World Health Organization member states agreed to the treaty after three years of talks. NPR speaks with Precious Matsoso, who served as co-chair of the group tasked with creating the treaty.

Aging men and social connection. Is there a disconnect?

"ROMEO" stands for "retired older men eating out" -- and it's one way to keep older guys from being too isolated. Just don't call it a support group!

Here's how to use nasal spray right and more tips for managing spring allergies

Here's the lowdown from allergy doctors on how to get relief, from which medicines to use — and how to best use them — to tips for keeping pollen out of your home.

On Autism, Kennedy Turns Against Science and Reality

During his first news conference as Health and Human Services secretary, Robert F. Kennedy Jr. on April 16 ticked off things he thinks kids with autism will never do, including paying taxes, holding …

The CDC staff in charge of injury prevention — a lead cause of death — has been cut

Injury is the leading cause of death for people under the age of 45. But much of the staff at the CDC responsible for studying how to track and prevent injuries were cut during the recent firings.